Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504-Reference-Cited by-同舟云学术

Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

Published:2023-03 Issue:4 Volume:115 Page:847-860
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Gillison Maura L.,Ferris Robert L.,Harris Jonathan,Colevas A. Dimitrios,Mell Loren K.,Kong Christina,Jordan Richard C.,Moore Kevin L.,Truong Minh-Tam,Kirsch Claudia,Chakravarti Arnab,Blakaj Dukagjin M.,Clump David A.,Ohr James P.,Deeken John F.,Gensheimer Michael F.,Saba Nabil F.,Dorth Jennifer A.,Rosenthal David I.,Leidner Rom S.,Kimple Randall J.,Machtay Mitchell,Curran Walter J.,Torres-Saavedra Pedro,Le Quynh Thu

Funder

National Cancer Institute

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference28 articles.

1. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

2. Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG oncology RTOG 0129 and 0522;Bigelow;Head Neck,2022

3. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522;Ang;J Clin Oncol,2014

4. PD-1 status in CD8(+) T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer;Kansy;Cancer Res,2017

5. Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma;Hartman;Oral Oncol,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders;Oral Oncology;2024-11

2. The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review;JNCI: Journal of the National Cancer Institute;2024-04-27

3. Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways;Experimental Hematology & Oncology;2024-04-23

4. Evolving role of novel radiosensitizers and immune checkpoint inhibitors in (chemo)radiotherapy of locally advanced head and neck squamous cell carcinoma;Oral Oncology;2023-10

5. Enhancement of Immunotherapies in Head and Neck Cancers Using Biomaterial-Based Treatment Strategies;Tissue Engineering Part C: Methods;2023-06-01